Alis J. Dicpinigaitis

Cerebrovascular and Neuro-Oncology

[Journal of Clinical Neuroscience @_jocn]

National trends in infectious intracranial aneurysm management: Endovascular treatment ↑, open surgery ↓ from 2000 to 2019—with no difference in in-hospital mortality. Important implications for IE-associated cerebrovascular disease.

🔗 https://t.co/K8jnyiA8P4

#NeurocriticalCare #NeuroIntervention #Stroke #Endocarditis #TCD #Neurosurgery

[Giana Dawod, MD @gdawod1]

A project inspired by cases I saw early on in residency, being consulted from the CVICU, for abnormal findings on CT/MRI & for heparin clearance, etc.

Excited to share our latest publication on mycotic aneurysm management trends:

https://t.co/YNNyMtxsML

@WCMCNeurology
@_jocn

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

Stroke is one of the few major diseases with a potential cure—yet it remains overlooked and underfunded.
On #WTD25, grateful to @MillEtienne & @Forbes for spotlighting that <3% worldwide receive thrombectomy.
We can—and must—do better.

https://t.co/uoIpLP6Ke4

#MissionThrombectomy #WTD25

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

In thrombectomy, lumen is power: Go big or go home.
The super-bore Cereglide 92 redefines aspiration:
🔹 82% thrombus reach
🔹 88% reperfusion
🔹 0% perforation or sICH
🔹 FPE in 50% overall, 61% when C-92 reached the clot
Proud to co-lead & serve as senior author on this non-industry sponsored study.
https://t.co/MqyXwrAPOX
#NoLVOleftbehind #Stroke #Thrombectomy #NeuroTwitter #Cereglide92 #EndovascularRevolution

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

“You Cannot Manage What You Do Not Measure”—a timeless principle that holds especially true in the fight against stroke.

Our latest paper, "You Cannot Manage What You Do Not Measure: Advances in Global Stroke Interventions and the Role of the Mechanical Thrombectomy Access Score", explores the evolving landscape of stroke care worldwide. We highlight how data-driven tools like the Mechanical Thrombectomy Access Score for Stroke can guide strategic planning, identify disparities, and accelerate equitable access to life-saving interventions.

Meaningful progress begins with measurement.

https://t.co/ll2FLYliaV

[Christian Bowers @bowersbrainsurg]

Fantastic paper by @adicpini shows that in &gt;13k chronic/subacute subdural hematomas, frailty status mattered the least in the 5% that were treated by middle meningeal artery embolization alone. MMAE embo may be used irrespective of frailty status!#frailtyfighters @NRADjournal

[Braydon Dymm, MD @BraydonDymm]

August saw the revision of a classic:

The Modified Hunt &amp; Hess Scale offers more accurate SAH patient outcome predictions.

Validated through 6,000+ cases from Columbia's SHOP database, it aims to replace the widely-used 1968 original scale.

https://t.co/4OdkuuJT8Q

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

Honored to serve as the Senior Investigator for the recently awarded @svinsociety - Pilot Scientific Grant, supporting our highly anticipated #TRIGEMINAL Trial for Migraine Headaches—(The Targeted Relief in Trigeminovascular Headaches through Middle Meningeal Artery Embolization)!

With over 39 million migraine sufferers in the U.S., our mission is to advance innovative treatments and improve quality of life for these patients.
Thrilled to collaborate with my fellow #ImanMoeini and #World renown headache specialsts as we work toward advancing treatments in this critical area.

#InnovationInNeurology #TRIGEMINALTrial #HeadacheResearch
#Migraine
@RaulNogueiraMD
@NguyenThanhMD @AmeerEHassan @PascalJabbourMD Jabbour @DavidAltschulMD @AshuPJadhav @elghanemmoh @AlAlBayati1 @TudorGJovin @AlexandraCzap

[Giana Dawod, MD @gdawod1]

#SVIN24 was a week ago, but the discussions regarding the latest in clinical trial updates are ongoing!

Check out these tables that @neurona_critica &amp; I put together to summarize the exciting new studies currently in the works to move us #ForwardTogether ⏩🧠💉🩸

@svinsociety

[Mission Thrombectomy @MThrombectomy]

Mission Thrombectomy is proud to have our Global Chair, Dr. Fawaz Al-Mufti, MD, @almuftifawaz at the UN General Assembly earlier this week in New York City, advocating for Global Thrombectomy access and Stroke care on behalf of us all!!
@svinsociety
@dyavagal
@NguyenThanhMD

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

Still using the #HuntHess scale from 1968 for SAH prognosis?

Many in the US and internationally continue to rely on this classic scale, following guidelines from @DNV_Group and @jcaho.

But medicine evolves, and so should our tools. It's prime time for an upgrade hence myself, @adicpini @Stephan @LochMacdonald decided to challenge the status quo!

Introducing the Modified Hunt & Hess (#mHH) Scale – delivering better outcomes with improved accuracy.

Check out our analysis of 6,130 SAHs validated using the @ColumbiaNCC #SHOP database, now in @SVINJournal:

Prognostication Following Aneurysmal Subarachnoid Hemorrhage: The Modified Hunt and Hess Grading Scale** | Stroke: Vascular and Interventional Neurology https://t.co/yGcrQ1wdTI"

[New York Symposium- Innovation in Neurosciences @NYNeuroendovasc]

Join us on June 14 in NYC on the #cuttingedge of Neurosciences!

The inaugural New York Symposium: Innovation in Neurosciences (NYS-IN) Conference #NYSIN24 at the historic New York Academy of Medicine featuring world-class Neurosciences KOLs
Register here: https://t.co/8HnD6hudP4

[Katie M Reitz MD MSc @MollReitz]

Big congrats ⁦@Katya_Khamzina⁩ ⁦@BowersNsgyLab⁩ for our hard work translating Risk Analysis Index to ICD codes-expanding applicability &amp; maintaining the hx of quality methods for identifying frailty ⁦@PittSurgery⁩ ⁦@HviUpmc⁩ https://t.co/qh28iCXrOV

[Bowers Neurosurgical Frailty and Outcomes Lab @BowersNsgyLab]

Exciting day with publication in the highest impact factor journal to date of all 100+ publications @JAMANetworkOpen &amp; 2 years of work to do this study @HurleyMedical

[Christian Bowers @bowersbrainsurg]

Congrats team @JAMANetworkOpen!! Risk Analysis Index for ICD-10 Dx coding (RAI for NIS!) @adicpini @MollReitz huge 🙏 @UPMC’s Dan Hall #frailtyfighters @BowersNsgyLab
Adaptation of the Risk Analysis Index for Frailty Assessment Using Diagnostic Codes https://t.co/ZZwqla8OYH

[Giana Dawod, MD @gdawod1]

Despite being 1 of the most effective interventions in the #medical world, mechanical thrombectomy access for stroke continues to be an issue worldwide. Luckily, @MThrombectomy, @svinsociety, and today, @almuftifawaz, have continued to work towards bridging this access gap. @WHO

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

LASTE is out!

RCT of 333 pts w Large Core Ischemic Stroke of unrestricted size.

Thrombectomy assoc. w
Lower disability (mRS 4 vs.6🤔)
⬇️ mortality (36vs.55%)&amp;
⬆️ Hmg (9.6vs.5.7%).

Are they better off than dead? Family discussion is essential.

https://t.co/YwH8wEdB0a

[Christian Bowers @bowersbrainsurg]

Congratulations! Great teamwork & vital info since Meningiomas are the most common primary brain tumor (30% of all brain tumors) & the silver tsunami is upon us, w/ exponential increases in older Meningioma patients. #frailtyfighters @WHOCen@WHOCenterFrailt @GlobalFrailty @FrailtyScience

[Weill Cornell Neurology @WCMCNeurology]

Our 10th Annual #Neurology Resident Research Symposium was a great success last night! Congratulations to organizers Dr. Mary Vo, @ARZ_Neuro_Doc, Amy Kong + all residents and their faculty mentors!
@nyphospital @WeillCornell @MSKCancerCenter @WCM_BMRI

[Fawaz Al-Mufti, MD, FSVIN @almuftifawaz]

Welcome to the #cuttingedge @ the New York Symposium: Innovation in Neurosciences (IN-NYS) #IN2023 @ the @NYAMNYC NY Academy of Medicine!

Join neuroscience KOLs as they unveil the latest breakthroughs &amp; experience #Neuroinnovation.

Register here: https://t.co/uSO8Qr9EgQ